We will see the effect of Nimba and lodhra Araka Aschyotana in vataja abhish shyada We will also see the effect of olapetedine eye drop in vataja abhishyanda with special reference to allergic conjunctivitis

A Randomized Controlled Trial of Nimba-Lodhra Arka(eye drop)Aschyotana in Vataja Abhishyanda with special reference to Allergic conjunctivitis. - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092766

Enrollment

Registered

2025-08-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H102- Other acute conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 18-60 years 2.with anatomically normal ocular structurrs

Exclusion criteria

Exclusion criteria: Patients suffering from 1.exraocular disease like ptosis,eyelid tumor 2.posterior segment disease 3.traumatic and inflammatory conditions of eye.

Design outcomes

Primary

Measure	Time frame
1.To evaluate the efficacy of Nimba-Lodhra Arka Aschyotana in the management of Vataja Abhishyanda with special refrenece to Allergic Conjuctivitis. 2.To evaluate the efficacy of OlopetadineH 0.1% eye drop in the management of Vataja Abhishyanda with special reference to Allergic Conjunctivitis. 3.To comapre effect of Nimba- Lodhra Arka Aschyotana and Olopetadine h 0.1% eye drop in the management of Vataja Abhishynda with special reference to Allergic Conjunctivitis.Timepoint: 0th,3rd,5th,7th day of trial	—

Measure

Time frame

1.To evaluate the efficacy of Nimba-Lodhra Arka Aschyotana in the management of Vataja Abhishyanda with special refrenece to Allergic Conjuctivitis. 2.To evaluate the efficacy of OlopetadineH 0.1% eye drop in the management of Vataja Abhishyanda with special reference to Allergic Conjunctivitis. 3.To comapre effect of Nimba- Lodhra Arka Aschyotana and Olopetadine h 0.1% eye drop in the management of Vataja Abhishynda with special reference to Allergic Conjunctivitis.Timepoint: 0th,3rd,5th,7th day of trial

—

Secondary

Measure	Time frame
1.To study the concept of Vataja Abhishyanda according ayurvedic line of treatment. 2.To study Allergic Conjunctivitis according to modern point of view. 3.To review and study the literature of Aschyotana in detail.Timepoint: 0th,3rd,5th,7th day	—

Countries

India

Contacts

Public ContactMuskan Rahim Shaikh

Government Ayurved College

drapvaijwade@gmail.com9421756462

Outcome results